MagForce AG (BST:MF6)
Germany · Delayed Price · Currency is EUR 0.0040
0.00 (0.00%)
At close: Aug 13, 2025
MagForce AG Company Description
MagForce AG develops advanced nanomedicine for cancer therapies.
It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator.
MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
MagForce AG
| Country | Germany |
| Founded | 1997 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 33 |
| CEO | Benjamin Lipps |
Contact Details
Address: Max-Planck-Straße 3 Berlin, 12489 Germany | |
| Phone | 49 30 308 380 0 |
| Website | magforce.de |
Stock Details
| Ticker Symbol | MF6 |
| Exchange | Stuttgart Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Benjamin Lipps | Chief Executive Officer |
| Barbara Frankenberg | Head of Investor Relations |